Taiwan FDA registration 03720421aef1526203c1d4335ec7add3
Regal Hormone Binding Globulin Reagent
TW: 禮雅尚性荷爾蒙結合球蛋白試劑
Taiwan·Risk Class 2·DIASORIN INC.·Registered Dec 18, 2019 – Dec 18, 2029ActiveRegistration details
- Analysis ID
- 03720421aef1526203c1d4335ec7add3
- Customs Code
- DHA05603311200
Company information
- Manufacturer
- DIASORIN INC.
- Manufacturer Country
- United States
- Authorized Representative
- MEDRICH INSTRUMENT CO., LTD.
Product details
- Intended Use
- THIS PRODUCT IS PAIRED WITH LIAISON AND LIAISON XL TO QUANTIFY HUMAN SEROLOGICAL OR PLASMA NEUTERIN-BINDING GLOBULIN USING IN VITRO CHEMICAL COLD LIGHT IMMUNOASSAY (CLIA) TECHNOLOGY. This product is used to assist in the diagnosis of male hormone disorders.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Grade Material (Analysis Material Non-Analysis);; A.1680 睪固酮試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Dec 18, 2019
- Expiry Date
- Dec 18, 2029
About this record
Access comprehensive regulatory information for Regal Hormone Binding Globulin Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 03720421aef1526203c1d4335ec7add3 and manufactured by DIASORIN INC.. The authorized representative in Taiwan is MEDRICH INSTRUMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices